OHSU in the news

Overdoses killing more Oregonians as national figure drops

The Lund Report October 01, 2024
News outlets cover the latest CDC statistics revealing that illicit drug overdoses remain elevated in Oregon over the past year compared of the rest of the country, noting that dangerously potent illicit fentanyl arrived on the West Coast later than other areas of the country. Todd Korthuis, M.D., tells The Lund Report.

VIDEO: AAP president shares policy statements on opioids, early reading, school expulsion

Healio October 01, 2024
Healio records a video perspective by Benjamin Hoffman, M.D., president of the American Academy of Pediatrics, regarding policies on opioids in pain management for kids; promoting early childhood reading; and overzealous discipline for students who are neurodivergent, have behavioral issues or have experienced significant trauma. Regarding the last issue, he says, “We are hoping to move past a culture where suspension and expulsion were the answer and more toward a trauma-informed, inclusive approach to ensuring that every child has access to education and the resources they need to be able to learn and thrive."

Ethics Issues for Young Adults Vary Depending on Setting

Medical Ethics Advisor October 01, 2024
Medical Ethics Advisor covers a study by Sammie Lyons, M.D., that examines how ethical issues are handled for 18- to 26-year-olds who are sometimes cared for in pediatric settings and sometimes adult settings. She notes that at OHSU, there is a single ethics committee for both adult and pediatric patients, which is better for young adults. “When dividing an ethics committee into pediatric and adult subgroups, you are missing this particular patient panel that traverses both spaces,” she says.

Great Salt Lick auction raises $19,000

The Baker City Herald September 30, 2024
The Baker City Herald reports that the 16th annual Great Salt Lick auction raised $19,000 on Sept. 21 with proceeds going to Parkinson’s disease research at OHSU. Founded by local resident Whit Deschner, who was diagnosed with Parkinson’s in 2000, the event showcases salt blocks licked into sculptures by livestock and wildlife.

Aficamten improves outcomes in obstructive HCM via significant cardiac remodeling

Healio September 26, 2024
Aficamten shows promise for improving exercise capacity and quality of life for patients with obstructive HCM. Ahmad Masri, M.D., says, “Aficamten, as a next-in-class cardiac myosin inhibitor, is currently in development for the treatment of obstructive hypertrophic cardiomyopathy and reduces hypercontractility in the cardiac sarcomere.”
See more stories